Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q98897412 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010904.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q98897412 | ||
| 024 | ‡a 0000-0002-2612-0065 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q98897412 | ||
| 100 | 0 | ‡a David Wai-Meng Tai ‡c researcher ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a David Wai-Meng Tai ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center | ||
| 909 | ‡a (orcid) 0000000226120065 ‡9 1 | ||
| 919 | ‡a realworldefficacyandsafetyofimmunecheckpointinhibitorsinadvancedhepatocellularcarcinomaexperienceofatertiaryasiancenter ‡A Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 LC|n 88038216 | ||
| 996 | ‡2 LC|n 85012765 | ||
| 996 | ‡2 J9U|987007443562105171 | ||
| 996 | ‡2 ISNI|0000000385527241 | ||
| 996 | ‡2 ISNI|0000000043558777 | ||
| 996 | ‡2 LC|no2002086810 | ||
| 996 | ‡2 SUDOC|255824289 | ||
| 996 | ‡2 ISNI|0000000041880631 | ||
| 996 | ‡2 LC|no 94021253 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
